JERUSALEM, April 10 (Xinhua) — An international team of researchers from Israel, the United States, and China has developed a genetic method to reprogram a type of immune cell, turning them from cancer promoters to inhibitors, Israel’s Weizmann Institute of Science said in a statement on Thursday. Read full story
Date: April 11, 2025 6:00 am
Source: thestar.com.my